Cellective BioTherapy

About:

Cellective BioTherapy develops novel cellular and monoclonal antibody-based platforms to treat cancer, autoimmunity, and immunodeficiency.

Website: http://cellectivebiotherapy.com/

Top Investors: Sofinnova Investments, Eshelman Ventures

Description:

Cellective BioTherapy develops novel cellular and monoclonal antibody-based platforms to treat cancer, autoimmunity, and immunodeficiency. The biotechnology company focuses on the research and development of B cell-based cellular therapies for immunomodulation, immunodeficiency, and autoimmunity. It researches treatment for cancers, diabetes, asthma, and congenital and acquired immunodeficiency, and vaccine development.